Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical Study

BACKGROUND: In addition to demonstrated public health benefits on reducing transmission, it remains unclear how early antiretroviral therapy (ART) must be started after acquisition of human immunodeficiency virus (HIV) to maximize individual benefits. METHODS: We conducted an open-label randomized c...

Descripción completa

Guardado en:
Autores principales: Javier R. Lama, Rachel Bender Ignacio, Ricardo Alfaro, Jessica Ríos, Jorge A. Gallardo-Cartagena, Rogelio Valdez, Carolyn Bain, Karin Sosa Barbarán, Manuel Villarán, Christopher D. Pilcher, Pedro Gonzáles, Jorge Sánchez, Ann Duerr
Formato: Artículo
Lenguaje:inglés
Publicado: 2020
Materias:
Medicine
Human immunodeficiency virus (HIV)
Antiretroviral therapy
Sida
Randomized controlled trial
Immunology
Clinical trial
Virology
Intensive care medicine
Viral disease
Viral load
Internal medicine
Sexual and Gender Minorities
Adult
Female
Humans
Male
Peru epidemiology
HIV Infections drug therapy
Homosexuality, Male
CD4 Lymphocyte Count
Anti-HIV Agents therapeutic use
Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions
Life Sciences Immunology and Microbiology Virology HIV Research and Treatment
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Biological Research and Disease Studies
Acceso en línea:Ver en el sistema de origen
Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Sea el primero en dejar un comentario!
Para ver esta página, ingrese con su cuenta.

Ejemplares similares